SUS.STSTOHealthcare · Medical - Healthcare Information Services

Surgical Science Sweden AB (publ)

$38.00+1.55%(+$0.58)

TickerSpark Score

68/100

Solid

Valuation

Profitability

Growth

Health

Momentum

Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SUS.ST research report →

52-Week Range10% of range

Low $23.70

Current $38.00

High $162.60

Companywww.surgicalscience.com

Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; simbionix simulators; and robotic surgery simulators.

CEO: Tom Englund
IPO: 2017
Employees: 274
HQ: Gothenburg, SE

Price Chart

-74.33% · this period

Valuation

Market Cap: $1.94B
P/E: 37.14
P/S: 1.98
P/B: 0.44
EV/EBITDA: 9.78
Div Yield: 0.00%

Profitability

Gross Margin: 63.12%
Op Margin: 7.65%
Net Margin: 5.34%
ROE: 1.21%
ROIC: 1.14%

Growth & Income

Revenue: $992.34M · 12.25%
Net Income: $66.82M · -49.24%
EPS: $1.31 · -49.22%
Op Income: $108.97M
FCF YoY: -24.06%

Performance & Tape

52W High: $162.60
52W Low: $23.70
50D MA: $32.88
200D MA: $52.86
Beta: 0.57
Avg Volume: 263.97K

Get TickerSpark's AI analysis on SUS.ST

Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

30-day money-back guarantee · cancel anytime